Trial Profile
"Influence of Remicade (infliximab) in the skin proteome of psoriatic patients".
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2012
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Plaque psoriasis
- Focus Biomarker; Therapeutic Use
- 25 Feb 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 16 Jun 2011 New trial record